These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 33482697)

  • 21. Monensin inhibits glioblastoma angiogenesis via targeting multiple growth factor receptor signaling.
    Wan W; Zhang X; Huang C; Chen L; Yang X; Bao K; Peng T
    Biochem Biophys Res Commun; 2020 Sep; 530(2):479-484. PubMed ID: 32595038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date.
    Chinot OL
    Expert Rev Anticancer Ther; 2012 Nov; 12(11):1413-27. PubMed ID: 23249106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme.
    Soda Y; Myskiw C; Rommel A; Verma IM
    J Mol Med (Berl); 2013 Apr; 91(4):439-48. PubMed ID: 23512266
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel anti-angiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells.
    Moreno MJ; Ball M; Andrade MF; McDermid A; Stanimirovic DB
    Glia; 2006 Jun; 53(8):845-57. PubMed ID: 16586492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGF.
    Di Tacchio M; Macas J; Weissenberger J; Sommer K; Bähr O; Steinbach JP; Senft C; Seifert V; Glas M; Herrlinger U; Krex D; Meinhardt M; Weyerbrock A; Timmer M; Goldbrunner R; Deckert M; Scheel AH; Büttner R; Grauer OM; Schittenhelm J; Tabatabai G; Harter PN; Günther S; Devraj K; Plate KH; Reiss Y
    Cancer Immunol Res; 2019 Dec; 7(12):1910-1927. PubMed ID: 31597643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased Antiangiogenic Effect by Blocking CCL2-dependent Macrophages in a Rodent Glioblastoma Model: Correlation Study with Dynamic Susceptibility Contrast Perfusion MRI.
    Cho HR; Kumari N; Thi Vu H; Kim H; Park CK; Choi SH
    Sci Rep; 2019 Jul; 9(1):11085. PubMed ID: 31366997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel anti-angiogenic therapies for malignant gliomas.
    Norden AD; Drappatz J; Wen PY
    Lancet Neurol; 2008 Dec; 7(12):1152-60. PubMed ID: 19007739
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiogenesis inhibitors in tackling recurrent glioblastoma.
    Hundsberger T; Reardon DA; Wen PY
    Expert Rev Anticancer Ther; 2017 Jun; 17(6):507-515. PubMed ID: 28438066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme.
    Charalambous C; Chen TC; Hofman FM
    Neurosurg Focus; 2006 Apr; 20(4):E22. PubMed ID: 16709028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiangiogenic therapy for high-grade glioma.
    Khasraw M; Ameratunga MS; Grant R; Wheeler H; Pavlakis N
    Cochrane Database Syst Rev; 2014 Sep; (9):CD008218. PubMed ID: 25242542
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in Anti-Cancer Drug Development: Metformin as Anti-Angiogenic Supplemental Treatment for Glioblastoma.
    Shah S; Mansour HM; Aguilar TM; Lucke-Wold B
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891882
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo.
    Grodzik M; Sawosz E; Wierzbicki M; Orlowski P; Hotowy A; Niemiec T; Szmidt M; Mitura K; Chwalibog A
    Int J Nanomedicine; 2011; 6():3041-8. PubMed ID: 22162660
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SDF-1 Blockade Enhances Anti-VEGF Therapy of Glioblastoma and Can Be Monitored by MRI.
    Deng L; Stafford JH; Liu SC; Chernikova SB; Merchant M; Recht L; Martin Brown J
    Neoplasia; 2017 Jan; 19(1):1-7. PubMed ID: 27940247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis.
    Cui X; Morales RT; Qian W; Wang H; Gagner JP; Dolgalev I; Placantonakis D; Zagzag D; Cimmino L; Snuderl M; Lam RHW; Chen W
    Biomaterials; 2018 Apr; 161():164-178. PubMed ID: 29421553
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of avastin in the management of recurrent glioblastoma.
    Sweet JA; Feinberg ML; Sherman JH
    Neurosurg Clin N Am; 2012 Apr; 23(2):331-41, x. PubMed ID: 22440876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia upregulates HIG2 expression and contributes to bevacizumab resistance in glioblastoma.
    Mao XG; Wang C; Liu DY; Zhang X; Wang L; Yan M; Zhang W; Zhu J; Li ZC; Mi C; Tian JY; Hou GD; Miao SY; Song ZX; Li JC; Xue XY
    Oncotarget; 2016 Jul; 7(30):47808-47820. PubMed ID: 27329597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vessel pruning or healing: endothelial metabolism as a novel target?
    Cantelmo AR; Pircher A; Kalucka J; Carmeliet P
    Expert Opin Ther Targets; 2017 Mar; 21(3):239-247. PubMed ID: 28081641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current status of antiangiogenic therapies for glioblastomas.
    Arrillaga-Romany I; Reardon DA; Wen PY
    Expert Opin Investig Drugs; 2014 Feb; 23(2):199-210. PubMed ID: 24320142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiogenesis in human brain tumors: screening of drug response through a patient-specific cell platform for personalized therapy.
    Guarnaccia L; Navone SE; Trombetta E; Cordiglieri C; Cherubini A; Crisà FM; Rampini P; Miozzo M; Fontana L; Caroli M; Locatelli M; Riboni L; Campanella R; Marfia G
    Sci Rep; 2018 Jun; 8(1):8748. PubMed ID: 29884885
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is there a world beyond bevacizumab in targeting angiogenesis in glioblastoma?
    Seystahl K; Weller M
    Expert Opin Investig Drugs; 2012 May; 21(5):605-17. PubMed ID: 22413865
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.